<bill session="108" type="h" number="2161" updated="2013-07-14T19:01:24-04:00">
  <state datetime="2003-05-20">REFERRED</state>
  <status>
    <introduced datetime="2003-05-20"/>
  </status>
  <introduced datetime="2003-05-20"/>
  <titles>
    <title as="introduced" type="short">Prescription Value Act</title>
    <title as="introduced" type="official">To require the Agency for Healthcare Research and Quality to collect and assess scientific evidence regarding prescription drugs frequently used by Medicare or Medicaid beneficiaries, and for other purposes.</title>
  </titles>
  <sponsor id="400023"/>
  <cosponsors>
    <cosponsor id="400007" joined="2003-06-03"/>
    <cosponsor id="400121" joined="2003-06-05"/>
    <cosponsor id="400164" joined="2003-05-22"/>
  </cosponsors>
  <actions>
    <action state="REFERRED" datetime="2003-05-20">
      <text>Referred to the House Committee on Energy and Commerce.</text>
    </action>
    <action datetime="2003-06-02">
      <text>Referred to the Subcommittee on Health.</text>
      <committee name="House Committee on Energy and Commerce"/>
    </action>
  </actions>
  <committees>
    <committee code="HSIF" name="House Energy and Commerce" activity="Referral, In Committee"/>
    <committee activity="Referral" code="HSIF14" subcommittee="Health" name="House Energy and Commerce"/>
  </committees>
  <relatedbills/>
  <subjects>
    <term name="Health"/>
    <term name="Congress"/>
    <term name="Congressional reporting requirements"/>
    <term name="Cost effectiveness"/>
    <term name="Drug utilization"/>
    <term name="Drugs"/>
    <term name="Government operations and politics"/>
    <term name="Government paperwork"/>
    <term name="Governmental investigations"/>
    <term name="Medicaid"/>
    <term name="Medicare"/>
    <term name="Pharmaceutical research"/>
    <term name="Science, technology, communications"/>
    <term name="Social welfare"/>
  </subjects>
  <amendments/>
  <summary>5/20/2003--Introduced.
Prescription Value Act - Directs the Director of the Agency for Healthcare Research and Quality to: (1) collect scientific evidence regarding the relative clinical appropriateness and cost-effectiveness of prescription drugs frequently used by Medicare and Medicaid beneficiaries; (2) assess the validity and reliability of such evidence; and (3) identify areas of additional research needed to make an objective determination on the clinical appropriateness and cost-effectiveness of such drugs.</summary>
</bill>
